Cost Effectiveness Analysis of Fecal Transplant Delivery Methods for Recurrent Clostridium difficile Infections in Outpatients

BACKGROUND: Clostridium difficile infection (CDI) accounts for more than $1 billion annually in US health care costs. Recurrent CDI (RCDI, recurrence within 8 weeks of initial treatment) contributes substantially to this cost. The objective of the study was to compare the cost effectiveness of FMT d...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Jeremey, Gundacker, Nathan, Rodriguez, Martin, Eaton, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630807/
http://dx.doi.org/10.1093/ofid/ofx163.960

Ejemplares similares

Ejemplares similares